Insulin growth factor-based dosing of growth hormone therapy in children: a randomized, controlled study.
about
Computerized advice on drug dosage to improve prescribing practiceThe first-year growth response to growth hormone treatment predicts the long-term prepubertal growth response in childrenRecombinant Human Insulin-Like Growth Factor-1 Treatment: Prime Time or Timeout? [Commentary on "Recombinant Human Insulin Like Growth Factor-1 Treatment: Ready for Prime Time" by Bright GM, Mendoza JR, Rosenfeld RG, Endocrinol Metab Clin N Am 2009;Dose-sparing and safety-enhancing effects of an IGF-I-based dosing regimen in short children treated with growth hormone in a 2-year randomized controlled trial: therapeutic and pharmacoeconomic considerations.Comparative proteomic analysis in children with idiopathic short stature (ISS) before and after short-term recombinant human growth hormone (rhGH) therapy.A randomized pilot trial of growth hormone with anastrozole versus growth hormone alone, starting at the very end of puberty in adolescents with idiopathic short statureGenetic and Epigenetic Modulation of Growth Hormone Sensitivity Studied With the IGF-1 Generation Test.Growth hormone (GH) dose-dependent IGF-I response relates to pubertal height gain.Comparison of response to 2-years' growth hormone treatment in children with isolated growth hormone deficiency, born small for gestational age, idiopathic short stature, or multiple pituitary hormone deficiency: combined results from two large obseThe variability of responses to growth hormone therapy in children with short statureEfficacy and Safety of Up to 8 Years of Long-term Growth Hormone Treatment in Short Children Born Small for Gestational Age in Japan: Analysis of the Subpopulation According to the Japanese GuidelineEfficacy of short-term growth hormone treatment in prepubertal children with idiopathic short stature.Pharmacogenomics of insulin-like growth factor-I generation during GH treatment in children with GH deficiency or Turner syndrome.The role and future challenges for recombinant growth hormone therapy to promote growth in children after renal transplantation.How useful are serum IGF-I measurements for managing GH replacement therapy in adults and children?Growth hormone deficiency: optimizing therapy and new issues.Endocrine phenotype of children and adults with Fanconi anemia.Identification and management of poor response to growth-promoting therapy in children with short stature.Treatment of Pre-pubertal Patients with Growth Hormone Deficiency: Patterns in Growth Hormone Dosage and IGF-I Z-scores.Is insulin-like growth factor-I a good marker for treatment adherence in growth hormone deficiency in adulthood?Final height and insulin-like growth factor-1 in children with medulloblastoma treated with growth hormone.Efficacy of IGF-based growth hormone (GH) dosing in nonGH-deficient (nonGHD) short stature children with low IGF-I is not related to basal IGF-I levels.Using a spontaneous profile rather than stimulation test makes the KIGS idiopathic growth hormone deficiency model more accessible for clinicians.Decreased GH dose after the catch-up growth period maintains metabolic outcome in short prepubertal children with and without classic GH deficiency.
P2860
Q24202497-F7F25B83-A519-4AD0-BFE1-F053E3DFC41AQ33399283-41E4E343-40D4-4959-967D-7CB5A67A78A9Q33651859-6F61D3F1-05AE-41C8-AD35-39FC683AAEE7Q34159910-A3584C47-883C-43A4-95F9-7DC16D42197DQ34597821-9D5FEE9C-C3A6-4853-A9D4-93A1B7A189BFQ35601201-95B7ADD1-7C52-47C2-9D64-4871E18B149EQ35680877-8062F2D2-6503-4A4C-B4A0-CB0E9EDCAD63Q35872930-9B5A6111-CD3B-46A4-90EC-BB20447D1918Q36232825-0F93FC37-0528-463E-8D66-317F0945F46FQ36701011-AB795BAA-FAB3-49BE-90C1-F5ACEAAEFFACQ36943226-A84263B4-E4F3-4DE1-97FC-821A72BD0957Q37418844-B2417B1B-C819-4C71-B50B-62A039C27FBFQ37646786-98C07FC5-B4AD-492E-A0A5-B8B9BFBE73FDQ37873551-FCC51795-107C-411B-ADCD-634368A6E63CQ37930510-EC525C65-FB2A-4467-B194-2A8D4C69C4D6Q37950854-B3BB43EE-8C90-4375-8B50-54658C572DAFQ37980408-150B0A59-5AE9-47E4-BB25-EC4A23B314B1Q38006057-F677EC6F-95A4-4D08-A350-2DC840D311CDQ39115022-92432CD6-96BB-4A3E-8C06-ACBE94B1C808Q40044224-EA233D38-2057-4CA3-B01A-E1C19327B579Q43683857-56B00509-6E10-4D53-8376-79B12B71A5FBQ46562800-B65B0B58-7FBA-4D6A-B61E-AEB0F8A038AFQ48644407-E9029E3E-503C-40AE-9187-04668C449D66Q51359657-D52DB030-33BC-47CC-87D5-FD50FAFB53B0
P2860
Insulin growth factor-based dosing of growth hormone therapy in children: a randomized, controlled study.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Insulin growth factor-based do ...... randomized, controlled study.
@en
Insulin growth factor-based do ...... randomized, controlled study.
@nl
type
label
Insulin growth factor-based do ...... randomized, controlled study.
@en
Insulin growth factor-based do ...... randomized, controlled study.
@nl
prefLabel
Insulin growth factor-based do ...... randomized, controlled study.
@en
Insulin growth factor-based do ...... randomized, controlled study.
@nl
P2093
P356
P1476
Insulin growth factor-based do ...... randomized, controlled study.
@en
P2093
Alan D Rogol
American Norditropin Study Group
Anne-Marie Kappelgaard
Campbell P Howard
George M Bright
Pinchas Cohen
Ron G Rosenfeld
P304
P356
10.1210/JC.2007-0204
P407
P577
2007-03-13T00:00:00Z